🇺🇸 FDA
Pipeline program

VIR-1111

VIR-1111-2001

Phase 1 mab completed

Quick answer

VIR-1111 for HIV I Infection is a Phase 1 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Vir Biotechnology
Indication
HIV I Infection
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials